Found: 16
Select item for more details and to access through your institution.
Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis.
- Published in:
- Medical Mycology, 2018, v. 56, n. 3, p. 288, doi. 10.1093/mmy/myx040
- By:
- Publication type:
- Article
A multivariate investigation into the relationship between pharmaceutical characteristics and patient preferences of bioequivalent ibuprofen tablets.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 1927, doi. 10.2147/PPA.S174479
- By:
- Publication type:
- Article
Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis.
- Published in:
- Molecules, 2020, v. 25, n. 6, p. 1394, doi. 10.3390/molecules25061394
- By:
- Publication type:
- Article
Permeability Characteristics of a New Antifungal Topical Amphotericin B Formulation with γ-Cyclodextrins.
- Published in:
- Molecules, 2018, v. 23, n. 12, p. 3349, doi. 10.3390/molecules23123349
- By:
- Publication type:
- Article
Effect of enantiomerism on the bioequivalence of a new ibuprofen 600‐mg tablet formulation obtained by roller compaction.
- Published in:
- Chirality, 2020, v. 32, n. 2, p. 185, doi. 10.1002/chir.23148
- By:
- Publication type:
- Article
Stereoselective drug release from Ketoprofen and Ricobendazole matrix tablets.
- Published in:
- Chirality, 1999, v. 11, n. 8, p. 611, doi. 10.1002/(SICI)1520-636X(1999)11:8<611::AID-CHIR1>3.0.CO;2-Z
- By:
- Publication type:
- Article
Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
- Published in:
- Diseases, 2021, v. 9, n. 2, p. 27, doi. 10.3390/diseases9020027
- By:
- Publication type:
- Article
Antileishmanial Drug Discovery and Development: Time to Reset the Model?
- Published in:
- Microorganisms, 2021, v. 9, n. 12, p. 1, doi. 10.3390/microorganisms9122500
- By:
- Publication type:
- Article
Application of Accelerated Predictive Stability Studies in Extemporaneously Compounded Formulations of Chlorhexidine to Assess the Shelf Life.
- Published in:
- Molecules, 2023, v. 28, n. 23, p. 7925, doi. 10.3390/molecules28237925
- By:
- Publication type:
- Article
Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution.
- Published in:
- BMC Veterinary Research, 2012, v. 8, n. 1, p. 71, doi. 10.1186/1746-6148-8-71
- By:
- Publication type:
- Article
Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics.
- Published in:
- Antioxidants, 2023, v. 12, n. 2, p. 397, doi. 10.3390/antiox12020397
- By:
- Publication type:
- Article
Guiding Clinical Prescription of Topical Extemporaneous Formulations of Sodium Cromoglycate Based on Pharmaceutical Performance.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 6, p. 1609, doi. 10.3390/pharmaceutics15061609
- By:
- Publication type:
- Article
In Vitro and In Vivo Characteristics of Olive Oil as Excipient for Topical Administration.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2615, doi. 10.3390/pharmaceutics14122615
- By:
- Publication type:
- Article
Tailoring Rational Manufacturing of Extemporaneous Compounding Oral Dosage Formulations with a Low Dose of Minoxidil.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 3, p. 658, doi. 10.3390/pharmaceutics14030658
- By:
- Publication type:
- Article
One and Two-Step In Vitro-In Vivo Correlations Based on USP IV Dynamic Dissolution Applied to Four Sodium Montelukast Products.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 690, doi. 10.3390/pharmaceutics13050690
- By:
- Publication type:
- Article
Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC® Natural Adjuvant against Aspergillosis.
- Published in:
- Pharmaceutics, 2019, v. 11, n. 9, p. 456, doi. 10.3390/pharmaceutics11090456
- By:
- Publication type:
- Article